Stockscreener 앱 받기
462.08
0.12%
-0.9056
전일 마감가:
$462.99
열려 있는:
$462.67
하루 거래량:
47,402
Relative Volume:
0.03
시가총액:
$117.24B
수익:
$11.74B
순이익/손실:
$3.68B
주가수익비율:
32.57
EPS:
14.1888
순현금흐름:
$3.34B
1주 성능:
+1.37%
1개월 성능:
+7.00%
6개월 성능:
+4.29%
1년 성능:
+12.61%
1일 변동 폭
$461.43
$463.65
1주일 범위
$453.03
$464.44
52주 변동 폭
$362.50
$519.68
버텍스 파마슈티컬 Stock (VRTX) Company Profile
명칭
Vertex Pharmaceuticals Inc
전화
(617) 341-6393
주소
50 NORTHERN AVENUE, BOSTON, MA
VRTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VRTX
Vertex Pharmaceuticals Inc
|
462.09 | 117.47B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.26 | 82.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.99 | 52.94B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
844.22 | 52.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.65 | 37.84B | 447.02M | -1.18B | -906.14M | -6.1812 |
버텍스 파마슈티컬 Stock (VRTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-03 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-09-25 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-09-03 | 개시 | Raymond James | Mkt Perform |
| 2025-08-06 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2025-05-07 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2025-05-06 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-04-22 | 재개 | Cantor Fitzgerald | Overweight |
| 2025-02-12 | 업그레이드 | Canaccord Genuity | Sell → Hold |
| 2025-02-11 | 업그레이드 | Canaccord Genuity | Sell → Hold |
| 2025-01-30 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-12-20 | 재확인 | H.C. Wainwright | Buy |
| 2024-12-19 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-12-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-11-14 | 개시 | Citigroup | Buy |
| 2024-10-16 | 개시 | Scotiabank | Sector Perform |
| 2024-10-10 | 재개 | Raymond James | Mkt Perform |
| 2024-08-05 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2024-06-27 | 개시 | Redburn Atlantic | Buy |
| 2024-04-11 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2024-02-15 | 개시 | Wolfe Research | Outperform |
| 2024-02-06 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2024-02-02 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2024-01-31 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2024-01-31 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2024-01-24 | 다운그레이드 | Canaccord Genuity | Hold → Sell |
| 2023-12-14 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2023-05-30 | 개시 | William Blair | Outperform |
| 2023-05-04 | 재개 | Piper Sandler | Overweight |
| 2023-03-21 | 개시 | Bernstein | Outperform |
| 2023-01-18 | 개시 | Canaccord Genuity | Hold |
| 2023-01-17 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-12-19 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-07-13 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-06-01 | 업그레이드 | Maxim Group | Hold → Buy |
| 2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
| 2022-05-06 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-05-03 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2022-02-03 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-01-27 | 재확인 | JP Morgan | Overweight |
| 2022-01-27 | 재확인 | Morgan Stanley | Underweight |
| 2022-01-27 | 재확인 | RBC Capital Mkts | Outperform |
| 2022-01-27 | 재확인 | Stifel | Hold |
| 2022-01-27 | 재확인 | Wolfe Research | Outperform |
| 2022-01-20 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2021-12-09 | 개시 | Wells Fargo | Overweight |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-11-19 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-09-09 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2021-07-20 | 다운그레이드 | SVB Leerink | Mkt Perform → Underperform |
| 2021-07-19 | 재개 | Wolfe Research | Outperform |
| 2021-07-01 | 개시 | Raymond James | Mkt Perform |
| 2021-06-11 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2021-02-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2021-02-02 | 재확인 | H.C. Wainwright | Buy |
| 2020-12-30 | 개시 | Daiwa Securities | Outperform |
| 2020-11-30 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-11-20 | 개시 | Bernstein | Outperform |
| 2020-10-28 | 개시 | UBS | Buy |
| 2020-07-31 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-08 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-04-30 | 재확인 | H.C. Wainwright | Buy |
| 2020-04-28 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-03-04 | 개시 | Barclays | Overweight |
| 2020-01-31 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-11-19 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-11-12 | 개시 | SunTrust | Buy |
| 2019-10-17 | 재개 | BofA/Merrill | Buy |
| 2019-09-03 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-08-01 | 다운그레이드 | Needham | Buy → Hold |
| 2019-05-23 | 재개 | Citigroup | Buy |
| 2019-05-21 | 개시 | Credit Suisse | Outperform |
| 2019-04-12 | 개시 | Evercore ISI | In-line |
| 2019-03-26 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2019-03-19 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2019-02-06 | 다운그레이드 | Maxim Group | Buy → Hold |
모두보기
버텍스 파마슈티컬 주식(VRTX)의 최신 뉴스
Biotech Stocks To Keep An Eye OnDecember 24th - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Bought by Vontobel Holding Ltd. - MarketBeat
GLOBALT Investments LLC GA Has $1.87 Million Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Leerink Partners Adjusts Price Target on Vertex Pharmaceuticals to $525 From $456 - marketscreener.com
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by DAVENPORT & Co LLC - MarketBeat
Is CRISPR Therapeutics Stock Yesterday's News? - The Motley Fool
Andrew Hill Investment Advisors Inc. Sells 4,294 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Anderson Hoagland & Co. - MarketBeat
Vertex Pharmaceuticals Incorporated (VRTX) is a trending stock: Facts to know before betting on it - MSN
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Vertex Pharmaceuticals (VRTX): Valuation Check After Positive CASGEVY Pediatric Data and Kidney Disease Breakthrough Progress - Yahoo Finance UK
Vertex to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12 - Business Wire
Vertex Pharmaceuticals: Strong Journavx Launch and Durable CF Franchise Underpin Buy Rating and Long-Term Growth Upside - TipRanks
Vertex Pharmaceuticals (VRTX) Stock Week Ahead: Holiday-Shortened Trading, New Gene-Therapy Data, and Fresh Analyst Targets (Dec. 22–26, 2025) - ts2.tech
Best Biotech Stocks To Watch TodayDecember 21st - MarketBeat
Best Biotech Stocks To Watch NowDecember 16th - MarketBeat
Foster Victor Wealth Advisors LLC Has $13.66 Million Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Flputnam Investment Management Co. Sells 3,065 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Congress Asset Management Co. Cuts Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals (VRTX) Stock News, Forecasts and Analyst Outlook on Dec. 20, 2025: Casgevy Pediatric Data, Kidney Pipeline Momentum, and Journavx Launch Watch - ts2.tech
Redhawk Wealth Advisors Inc. Lowers Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
LVM Capital Management Ltd. MI Trims Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals (VRTX) Stock After Hours on Dec. 19, 2025: Today’s News, Analyst Forecasts, and What to Know Before Monday’s Market Open - ts2.tech
Is Vertex Pharmaceuticals Incorporated stock ready for breakoutJuly 2025 Selloffs & Daily Entry Point Trade Alerts - Улправда
Aug Analyst Calls: Is Vertex Pharmaceuticals Incorporated stock ready for breakout2025 Price Targets & Weekly Sector Rotation Insights - ulpravda.ru
What dividend safety score for Vertex Pharmaceuticals Incorporated stockWeekly Investment Report & Weekly High Return Forecasts - Улправда
Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Voya Investment Management LLC Has $168.85 Million Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Montecito Bank & Trust Buys Shares of 2,239 Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Is Vertex Pharmaceuticals Incorporated stock attractive after correctionQuarterly Trade Summary & Daily Stock Trend Reports - Bölüm Sonu Canavarı
Is Vertex Pharmaceuticals Incorporated stock positioned well for digital economy2025 Technical Patterns & Weekly Breakout Watchlists - Улправда
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Ipswich Investment Management Co. Inc. - MarketBeat
Thurston Springer Miller Herd & Titak Inc. Sells 2,487 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Czech National Bank Increases Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
How analysts rate Vertex Pharmaceuticals Incorporated stock todayEarnings Miss & Reliable Intraday Trade Plans - Улправда
Vertex Pharmaceuticals Incorporated $VRTX Stake Lessened by Channel Wealth LLC - MarketBeat
Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Vertex Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Gradient Investments LLC Boosts Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Corient Private Wealth LLC Cuts Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Assenagon Asset Management S.A. Increases Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Vertex, Inc. (VERX) Stock News Today: Latest Price, AI Tax Automation Updates, Analyst Forecasts and Outlook (Dec. 16, 2025) - ts2.tech
Texas Permanent School Fund Corp Sells 9,892 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Shorepoint Capital Partners LLC Invests $4.08 Million in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
What's Driving the Market Sentiment Around Vertex Pharmaceuticals Inc?Vertex Pharmaceuticals (NASDAQ:VRTX) - Benzinga
National Bank of Canada FI Acquires 99,751 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Castleark Management LLC Cuts Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
B. Riley Wealth Advisors Inc. Buys Shares of 4,141 Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals (VRTX) Stock: What to Know Before the Market Opens on Dec. 15, 2025 - ts2.tech
MASTERINVEST Kapitalanlage GmbH Purchases Shares of 5,784 Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
버텍스 파마슈티컬 (VRTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.06%
0.08%
자본화:
|
볼륨(24시간):